1443333-67-2

Basic information

• Product Name: (1‐[6‐(acetylamino)‐6‐deoxy‐β‐D‐glucopyranosyl]‐4‐chloro‐3‐(4‐cyclopropylbenzyl)‐1H‐indole)
• Synonyms: (1‐[6‐(acetylamino)‐6‐deoxy‐β‐D‐glucopyranosyl]‐4‐chloro‐3‐(4‐cyclopropylbenzyl)‐1H‐indole)
• CAS NO: 1443333-67-2
• Molecular Weight: 484.98
• Mol File: 1443333-67-2.mol

Chemical Properties

• CAS DataBase Reference: (1‐[6‐(acetylamino)‐6‐deoxy‐β‐D‐glucopyranosyl]‐4‐chloro‐3‐(4‐cyclopropylbenzyl)‐1H‐indole)(CAS DataBase Reference)
• NIST Chemistry Reference: (1‐[6‐(acetylamino)‐6‐deoxy‐β‐D‐glucopyranosyl]‐4‐chloro‐3‐(4‐cyclopropylbenzyl)‐1H‐indole)(1443333-67-2)
• EPA Substance Registry System: (1‐[6‐(acetylamino)‐6‐deoxy‐β‐D‐glucopyranosyl]‐4‐chloro‐3‐(4‐cyclopropylbenzyl)‐1H‐indole)(1443333-67-2)

Safety Data

• Hazardous Substances Data: 1443333-67-2(Hazardous Substances Data)

Upstream product

• 1443333-03-6 1-(6-azido-6-deoxy-β-D-glucopyranosyl)-4-chloro-3-(4-cyclopropylbenzyl)-1H-indole 
• 1443333-08-1 1-(6-amino-6-deoxy-β-D-glucopyranosyl)-4-chloro-3-(4-cyclopropylbenzyl)-1H-indole 
• 75-36-5 acetyl chloride 

Relevant articles and documents

N-Indolylglycosides bearing modifications at the glucose C6-position as sodium-dependent glucose co-transporter 2 inhibitors

Suppression of glucose reabsorption through the inhibition of sodium-dependent glucose co-transporter 2 (SGLT2) is a promising therapeutic approach for the treatment of type 2 diabetes. To investigate the effect of C6-substitution on inhibition of SGLT2 b

NOVEL GLYCOSIDE COMPOUNDS

Compounds of formula (I): wherein X, Y, and Z are defined herein. Also disclosed are pharmaceutical compositions and therapeutical methods related to these compounds.